Home | Medical-Newswire.Com:
(Medical-NewsWire.com, September 20, 2012 ) New York, NY -- Advanced Medical Isotope Corporation (ADMD) is already a US-based manufacturer and distributor of medical isotopes and is also developing key technologies that may offer a superior alternative to the current standard of care for battling cancer with nuclear medicine.
In a Thursday report, VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors, identifies key point for optimism regarding the company and examines its speculative potential as an investment. Full report available at: http://vfcsstockhouse.com/blog/article/-advanced-medical-isotope-corporation-expanded-distribution-and-radiogel-technology-hold-the-keys-to-the-future
Advanced Medical Isotope Corporation (ADMD) has - through key partnerships, expanding distribution channels and the acquisition of a license to a novel cancer-fighting technology - well positioned itself to become a growth player in the field of nuclear medicine, specifically in the field of the production and distribution of medical isotopes. Medical isotopes are used in molecular imaging, therapy, and nuclear medicine to diagnose, manage and treat diseases and are deemed a hot item whenever discussed because of the geopolitical implications of non-nuclear nations attempt to enrich uranium for - ahem - solely medical purposes.
Advanced Medical is one of only a few companies in the United States manufacturing and distributing such isotopes and it's likely that business could quickly hit a growth spurt - not only through the company's own indigenous expansion and distribution efforts, but also because of the growing desire of the medical community in the US to use 'home grown' nuclear materials, not to mention increasing regulation that may force the community to do so anyway.
AMIC already offers a broad variety of isotopes and, as outlined in a recent quarterly report, is looking to expand its 'pipeline' of product offerings for its distribution network of customers that include - but is not limited to - national laboratories, hospitals, research facilities and universities.
Many of the company's isotopes are put to use through molecular imaging, or Positron Emission Tomography (PET), which enables Doctors and medical professionals to identify cancerous condictions well before detection means that search for tumor mass. Some of the radiopharmaceutical products based on the medical isotopes are also used in the early detection of certain cardiovascular indications and, as mentioned above, the demand for such products is growing, not shrinking. According to numbers identified in a recent company presentation and credited to the World Nuclear Association, the use of medical isotopes is growing at an annual rate of 10%.
That places AMIC right in the middle of a potential growth boom.
While production and distribution may encompass the company's core business model, AMIC is moving heavily into the field of treatment, too. The process of placing radioactive "seeds" in or near a cancerous tumor is known as brachytherapy, and AMIC is developing a pipeline based on such technology to augment the already-growing core business plan.
In April, the company acquired a license and numerous relating patents to an injectible radiogel technology that could have a significant impact on the next generation of fighting cancer. Using the radiogel technology doctors could deliver Yttrium-90 "microspheres" directly into cancerous tissue. Because the injectible polymer turns solid and holds the microspheres in place, there is little to no threat of any radiation escaping and damaging surrounding tissue. As described by Dr. Alan Walter, Chair of the AMIC Scientific Committee, in a presentation available on the company's home page, such a technology could be termed as using "smart bullets" to target cancerous cells.
Yttrium-90, in the form of Polymer seeds, is an already-established medical isotope with numerous applications in existing cancer treatment and has demonstrated effectiveness in combating head, neck, liver and prostate cancers, according to an above-linked company presentation. The radiogel application of Yttrium-90 could potentially 'storm the scene' in treating numerous cancer types with the intent of targeting those tumors in the hard-to-get to areas of the body that eliminates surgery as an option.
Both the Polymer seeds and the acquired the radiogel technology significantly boost the diversity of AMIC, offering a targeted path to enter the realm of caner treatment to augment the production, sales and distribution channels of its isotopes.
It's possible, based on previous expectations, that the Brachytherapy pipeline could hit market within a couple of years. At that point AMIC could either move forward with commercialization on its own or out-license the technology to someone else and use that revenue stream of royalties to fund the expansion of the core business.
Shares were up by eight percent on Wednesday, although volume was very light. That said, volume has been picking up significantly over the past few months and has tripled already once this year. Volume has also stormed in after the company's more relevant press releases, indicating that there are investors on the sidelines who either wait to play a quick trade or may be taking a 'wait and see' approach to playing this still-speculative stock.
Should the potential of the AMIC distribution network continue to expand and meet the growing demand for nuclear medicine - and should the polymer seeds and radiogel technology also hit market with momentum - then it's likely that the current ADMD share price could start to move. Currently, shares consistently trade for a few pennies above the twenty cents mark, give or take.
Based on the potential of the developing technology, already-available products and future product offerings, the current ADMD trading levels could serve as an opportune accumulation period to those looking at the risk/reward profile for the future. The current market cap of still under twenty million indicates that many investors are still unconvinced, but when searching for potential payoff picks on the bulletin board stocks, it pays off to be in while the stock is still moving along relatively unnoticed, as the best percentage gains to be had in any run start with being in place before the run starts.
That said, the stock market is risky business and there are no sure things, that's why it's up to each investor to conduct his or her own DD and invest accordingly.
Still a developing story worth monitoring.
Disclosure: No position.
Follow ADMD developments and other small cap stocks at VFCsStockHouse.com
Contact VFC's Stock House: email@example.com
Follow VFC's Stock House on Twitter: https://twitter.com/#!/VFCsStockHouse
'Like' VFC's Stock House on Facebook: http://www.facebook.com/pages/VFCs-Stock-House/143724412345213
VFC's Stock House is an information and research outlet that brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - biotech stocks, biopharma stocks, and pharmaceutical and healthcare stocks. VFC's Stock House provides individual company profiles, write-ups and reports as well as giving general insights and opinions into broader-market news. At the conclusion of most weeks, VFC's Stock House issues a "Weekly Stock Watch" that examines news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. The information contained within the pages of VFC’s Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and make informed and well thought-out investment decisions. For full disclaimer visit: http://vfcsstockhouse.com
VFC's Stock House
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on
top health stories.
Husband surprises wife with 500 roses after chemo treatment
1 Jul 2016 at 6:40pm
OMAHA, Neb. (AP) ? A dozen roses simply weren't enough for a Nebraska man who wanted "to do something special" for his wife to celebrate her last chemotherapy treatment. So, he raised money and surprised her with 500.
Mexico air lifts food into villages as teacher blockades spread
1 Jul 2016 at 4:59pm
Mexico's air force flew tons of grain to the southern state of Oaxaca on Friday as protests by teachers opposed to education reform spread across the country and road blocks led to dwindling food supplies in some remote regions. Tension in the state intensified after eight people died last month in clashes between police and the protesting teachers, and unrest has flared throughout Mexico. Local media reported protests by factions of Mexico's CNTE teachers union on Friday in the states of Guerrero, Oaxaca, Michoacan, Chiapas, Nuevo Leon and in Mexico City.
J&J's Janssen hit with $70 million verdict in Risperdal trial
1 Jul 2016 at 3:23pm
A U.S. jury on Friday awarded $70 million to the family of a boy who developed breasts after taking Johnson & Johnson unit Janssen Pharmaceuticals' antipsychotic drug Risperdal. Andrew Yount, of Tennessee, developed gynecomastia at the age of five as a result of taking Risperdal, his lawyers say. Johnson & Johnson and Janssen are facing more than 12,000 claims over Risperdal, according to Johnson & Johnson's most recent quarterly report.
Democrats' draft platform calls for reviews of trade deals
1 Jul 2016 at 2:27pm
WASHINGTON (Reuters) - The U.S. Democratic Party's 2016 policy platform calls for reviews of trade deals, wider health coverage through public programs such as Medicare, and federal investigations of fossil fuel companies accused of misleading shareholders on climate change, according to a draft version released on Friday. The committee drafting the platform last weekend approved the document, which spells out the party's policy priorities. It still must be formally adopted at the Democratic National Convention, to be held in Philadelphia in July. ...
Aetna launches Medicare Advantage asset sale: sources
1 Jul 2016 at 2:09pm
Merging Aetna's and Humana's Medicare Advantage businesses would make the combined company the largest U.S. manager of the healthcare insurance for seniors and the disabled. Aetna has sent out pitchbooks to potential buyers and will begin collecting bids as soon as next week, the people said on Friday.
Girls less likely to get pregnant if a friend has a baby
1 Jul 2016 at 1:42pm
By Linda Thrasybule (Reuters Health) - - Girls whose friends have experienced teen childbirth are less likely to get pregnant themselves, a new study suggests. In 2000-2001 - the fifth year after the start of the study - girls whose friends had given birth had about 25 fewer sexual intercourse encounters, on average, than girls whose friends had miscarried.
Uncertainty looms as Vermont becomes 1st state to label GMOs
1 Jul 2016 at 1:20pm
MONTPELIER, Vt. (AP) ? Democratic presidential candidate Bernie Sanders joined other Vermont leaders Friday to celebrate the state's newly implemented law requiring labels on genetically modified food and blast proposed federal legislation that could pre-empt the state requirement.
Many everyday common chemicals are endangering child brain development says n...
1 Jul 2016 at 12:46pm
A new report published in the journal Environmental Health Perspectives is calling for more attention to be paid to the growing evidence that exposure to many everyday common chemicals are causing harm to children's brain development. Dozens of scientists, health practitioners and children's health advocates have expressed their concern in the paper that these chemicals are disrupting brain development from as early as pregnancy with the effect continuing through to children of all ages.
Guinea-Bissau confirms three cases of Zika virus, government says
1 Jul 2016 at 12:19pm
Guinea-Bissau has confirmed its first three cases of the Zika virus in a group of islands off the mainland and has set up an emergency committee to stop further transmission of the disease, the government said on Friday. Experts have feared the tiny nation could become a gateway for Zika's spread to mainland West Africa, after an outbreak of the mosquito-borne virus was first recorded in the African island chain of Cape Verde late last year. "The Health Minister has informed (the government) of three confirmed cases of Zika virus contamination located in the Bijagos Archipelago," read a government statement sent to reporters.
Spain records first case of sexually transmitted Zika virus
1 Jul 2016 at 11:44am
Spain has recorded its first known case of the Zika virus being sexually transmitted, after a woman contracted it from her partner after he returned from a Latin American country, health authorities in Madrid said on Friday. The mosquito-borne Zika virus has been linked to thousands of cases of the microcephaly birth defect in countries such as Brazil, which has declared a public health emergency over the disease. The birth defect is marked by babies born with brain abnormalities and undersized heads.
Obama urges Congress to release Zika funds
1 Jul 2016 at 11:40am
US President Barack Obama urged Congress Friday to advance $1.9 billion in emergency funds to fight the Zika virus, saying Republicans should set aside politics to tackle the fast-moving disease. "This is not the time to play politics," Obama said in remarks delivered in the White House Oval Office following a meeting with National Institute of Allergy and Infectious Diseases chief Anthony Fauci and other officials. "Congress should not leave, should not adjourn, until they get this done," he added ahead of the Independence Day holiday weekend.
UK drugs regulator to halt approvals for Indian clinical trials firm
1 Jul 2016 at 11:40am
By Zeba Siddiqui MUMBAI (Reuters) - The UK's healthcare regulator has decided to suspended marketing approval for a widely used antibiotic that had won clearance based on clinical trials conducted by India's Quest Life Sciences, due to concerns over the integrity of trial data. The Medicines and Healthcare products Regulatory Agency (MHRA) might also deny other pending drug approval requests that rely on studies conducted by Quest, the UK agency said in a letter dated June 22, a copy of which was seen by Reuters. The MHRA's decision bars the sale of a generic version of erythromycin that is being sold in the UK by Dawa Ltd, a Kenyan drugmaker, an MHRA spokesman said.
People eat less when wearing ?bite counters?
1 Jul 2016 at 11:16am
By Madeline Kennedy People who wear ?bite counters? on their wrists while eating tend to cut down on how much they consume during a meal, a study suggests. Several years ago, Eric Muth and colleagues at Clemson University in South Carolina developed a way to track how much people eat based on their wrist motion. Muth told Reuters Health by email that self-monitoring is vital when trying to meet health goals.
Woman on FBI's top 10 fugitive list captured in North Carolina
1 Jul 2016 at 11:15am
Shanika Minor, 24, was captured by sheriff's deputies at a Fayetteville, North Carolina, motel near an airport at about 1:30 a.m., the FBI's Milwaukee office said in a statement. Deputies located Minor after someone called the FBI's public tip line with information about her whereabouts, the FBI said. Minor, who is being temporarily held at the Cumberland County Detention Center in Fayetteville, faces a top charge of intentional homicide, the FBI said.
Correction: Coal Jobs vs Air Pollution story
1 Jul 2016 at 11:04am
OAKLAND, Calif. (AP) ? In a story June 28 about a proposed coal ban in Oakland, The Associated Press reported erroneously the name of the organization that David Smith represents. He is an attorney for the Oakland Bulk and Oversized Terminal, not the Oregon Bulk and Oversized Terminal.